This study reports the chemical synthesis of a series of structurally defined oligosaccharide derivatives related to the galactomannan polysaccharide of Antrodia cinnamomea, employing a stepwise glycosylation strategy. Structure-immunostimulatory activity relationship studies demonstrated that, within this series of precisely designed and synthesized compounds, those incorporating a continuous trimannose epitope—such as tetrasaccharides 2a, 2b, 2e and trimannoside 3c—exhibited significant proliferative activity against both the murine monocytic macrophage leukemia RAW264.7 cell and the human monocytic leukemia THP-1 cell. These findings elucidate the structural basis of the active core fragment of A. cinnamomea galactomannan polysaccharide and provide a molecular foundation for the rational design and development of novel immunomodulatory agents.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: